ACCELON
Live / Registered — Registered (as of 18 May 2021)
What this means for you
Registered since 18 May 2021. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 87112018
- Registration number
- 6356164
- Mark type
- Stylized text
- Filed
- 21 Jul 2016
- Published for opposition
- 20 Jun 2017
- Registered
- 18 May 2021
- Attorney of record
- Sarah M. Robertson
Goods and services
- Class 001 — Chemicals: Excipients for use in the manufacture of pharmaceutical preparations and/or dietary supplements
- Class 005 — Pharmaceuticals: Excipients sold as an ingredient of dietary and nutritional supplements; excipients sold as an ingredient of dietary and nutritional supplements for endurance sports; excipients sold as an ingredient of medicinal oils; excipients sold as an ingredient of dietetic foods, namely, omega 3 capsules, tablets, gels, chewables, smoothies, enteral feed formulas, liquid nutritive preparations for oral or tube feeding and nutritional bars with omega-3 formulation, adapted for medical purposes; excipients sold as an ingredient of biological preparations for the treatment or prevention of cancer, cachexia, concussion, non-alcoholic fatty liver disease (NAFLD), non-alcoholic steatohepatitis (NASH), rheumatoid arthritis, hypertriglyceridemia (HTG), metabolic syndrome, sarcopenia, chronic inflammatory diseases and diabetes; excipients sold as an ingredient of dietetic beverages adapted for nutritional support for the treatment or prevention of cancer, cachexia, concussion, non-alcoholic fatty liver disease (NAFLD), non-alcoholic steatohepatitis (NASH), rheumatoid arthritis, hypertriglyceridemia (HTG), metabolic syndrome, sarcopenia, chronic inflammatory diseases and diabetes; excipients sold as an ingredient of dietetic substances, namely, omega-3 concentrate adapted for medical use; excipients sold as an ingredient of nutritional supplements adapted for medical use; excipients sold as an ingredient of nutritional supplements; excipients sold as an ingredient of food supplements for medical purposes
Owner
- BASF AS, OSLO, NO
- BASF AS, OSLO, NO
- Pronova Biopharma Norge AS, Oslo, NO
- Pronova Biopharma Norge AS, Oslo, NO
Prosecution history
- 18 May 2021 — REGISTERED-PRINCIPAL REGISTER
- 14 Apr 2021 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 13 Apr 2021 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 05 Feb 2021 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 05 Feb 2021 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 04 Feb 2021 — ASSIGNED TO LIE
- 02 Nov 2020 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 17 Jul 2020 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 17 Jul 2020 — NON-FINAL ACTION E-MAILED
- 17 Jul 2020 — SU - NON-FINAL ACTION - WRITTEN
- 02 Jun 2020 — STATEMENT OF USE PROCESSING COMPLETE
- 01 Jun 2020 — USE AMENDMENT FILED
- 01 Jun 2020 — TEAS STATEMENT OF USE RECEIVED
- 27 Feb 2020 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 26 Feb 2020 — SOU EXTENSION 5 GRANTED